Innovaderm, the leading medical dermatology and aesthetics Contract Research Organization (CRO), today announced that it has been selected by Clinical Leaders CRO Leadership Awards for the fourth consecutive year, excelling across core categories of Expertise, Capabilities, Quality, and Reliability.

Clinical Leaders CRO Leadership Awards, which include a collaboration with ISR Reports, provide readers with accurate and reliable customer feedback to assist them in choosing a reputable CRO partner. This year, more than 40 CROs were assessed on approximately 20 performance metrics on work completed in the past 18 months.

Innovaderm won top performer for “small pharma” in the Capabilities, Quality, and Reliability categories, and named champion in the Expertise (Overall, Small Pharma) category.

“We are proud to be recognized by the CRO Leadership Awards for the 4^th year running,” said Cedric Burg, COO at Innovaderm. “This honor is a testament to our unwavering commitment to excellence in dermatology and aesthetics clinical research. Our team’s dedication to providing top-tier service and delivering quality results has been instrumental in achieving this recognition. We remain committed to our mission of improving patients’ lives and will continue to strive for excellence in all that we do.”

With nearly 25 years of success and deep expertise in medical dermatology and aesthetics, Innovaderm stands as a leader in dermatology clinical research. The CRO’s comprehensive approach includes full-service capabilities and stand-alone biometrics and clinical regulatory services across all phases of clinical trials. Innovaderm excels in managing both late phase and early phase & translational studies. The operational teams, established in Europe and North America, are dedicated to improving patient lives. This commitment to excellence underscores every aspect of Innovaderm’s mission.

Innovaderm Research Inc.

Innovaderm Research Inc. is the leading full-service dermatology CRO. Founded in 2000, Innovaderm’s deep expertise and experience enable the ability to operationalize all aspects of clinical research, and deliver excellence across early to late phase studies. Innovaderm’s mission is to drive innovative research initiatives towards the goal of improving patients’ lives. To learn about Innovaderm’s services, visit our website.

Innovaderm Research Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240501792630/en/

Media:
Lisa Barbadora
Barbadora Ink for Innovaderm Research
barbadora@barbadoraink.com

Marla Kertzman
Barbadora Ink for Innovaderm Research
marla@thoroughbred-communications.com

Logo

Tags

More Like This

Innovaderm, a Key Collaborator in Clinical and Study Development for Recently Published Phase 1 Atopic Dermatitis Study

Innovaderm Research Appoints Ina Zschocke as New Executive Vice President, European Operations and Strategy

Specialist CRO Welcomes Dr Juan Gabriel Ovalles Bonilla as Medical Rheumatology Lead

Altasciences Receives 2024 CRO Leadership Award for Capabilities

Novotech Honored with Frost & Sullivan’s 2024 Best Practices Company of the Year Award for Leadership in Biotech CRO Services

Novotech Recognized for Excellence in Business Expansion, Innovation, and Marketing at the 2024 Clinical Trials Arena Excellence Awards

Novotech Executive Team at J.P. Morgan Healthcare Conference: Global CRO Designed for Biotechs Across 25 Regions

Linical Named Best Global CRO by Global Health & Pharma Magazine